IGF-I regulation of Na+-K+-ATPase in rat arterial smooth muscle

American Journal of Physiology - Endocrinology and Metabolism

Volumn 273, Issue 1 36-1, 1997, Pages

  Standley, Paul R ^a   Zhang, Feng ^b   Zayas, Ricardo M ^b   Muniyappa, Ranganath ^b   Walsh, Mary F ^b   Cragoe, Edward ^b   Sowers, James R ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

Hypertension; Insulin like growth factor; Sodium potassium adenosinetriphosphatase; Vascular smooth muscle

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); NITRIC OXIDE SYNTHASE; SOMATOMEDIN C;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL TONE; CELL MEMBRANE; DIABETES MELLITUS; HYPERTENSION; IMMUNOBLOTTING; MALE; MITOGENESIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTON SODIUM EXCHANGE; RAT; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0030767892     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.273.1.e113     Document Type: Article

References (40)

1. + pump sites in cultured vascular smooth muscle cells. Am. J. Physiol. 256 (Cell Physiol. 25): C786-C792, 1989.
2. 2-isoforms. Am. J. Physiol. 265 (Cell Physiol. 34): C680-687, 1993.
3. Cohick, W. S., A. Gockerman, and D. R. Clemmons. Regulation of IGF binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells. J. Cell. Physiol. 164: 187-196, 1995.
4. Copeland, K. C., and K. Sreekuran. Recombinant human insulin-like growth factor-1 increases forearm blood flow. J. Clin. Endocrinol. Metab. 79: 230-232, 1994.
5. Delfontaine, P., H. Lou, and R. W. Alexander. Regulation of insulin-like growth factor 1 messenger RNA levels in vascular smooth muscle cells. Hypertension 18: 742-747, 1994.
6. + transport in rat soleus muscle. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E849-E857, 1995.
7. +-deficient rats. Am. J. Physiol. 264 (Endocrinol. Metab. 27): E810-E815, 1993.
8. Ebina, Y., E. Araki, M. Taira, F. Shimada, M. Mori, C. S. Craik, K. Siddle, S. B. Pierce, R. A. Roth, and W. J. Rutter. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc. Natl. Acad. Sci. USA 84: 704-708, 1987.
9. Gockerman, A., and D. R. Clemmons. Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2. Circ. Res. 76: 514-521, 1995.
10. +-ATPase activity by nitric oxide: a cGMP-independent effect. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2146-H2151, 1994.
11. Haylor, J., I. Singh, and A. M. El-Nahas. Nitric oxide synthesis inhibitor prevents vasodilation by insulin like growth factor 1. Kidney Int. 39: 333-335, 1991.
12. +-ATPase α-subunit gene expression in hypertension. Science 241: 221-223, 1988.
13. +-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J. Biol. Chem. 267: 5040-5043, 1992.
14. +-ATPase messenger RNA expression in spontaneously hypertensive rat aorta. J. Vasc. Med. Biol. 4: 156-161, 1988.
15. Jacob, R., E. Barrett, G. Plewe, K. D. Fagin, and R. S. Sherwin. Acute effect of insulin-like growth factor 1 on glucose and amino acid metabolism in the awake fasted rat. J. Clin. Invest. 83: 1717-1721, 1989.
16. Kahn, A. M., C. L. Siedel, J. C. Allen, R. G. O'Neil, H. Shelat, and T. Song. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 22: 735-742, 1993.
17. King, G. L., A. D. Goodman, S. Buzrey, A. Masis, and C. R. Kahn. Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J. Clin. Invest. 75: 1028-1036, 1985.
18. Kleyman, T. R., and E. J. Cragoe. Amiloride and its analogs in the study of ion transport. J. Membr. Biol. 105: 1-21, 1988.
19. + adenosine triphosphatase regulation in hypertrophied vascular smooth muscle cells. Hypertension 20: 144-150, 1992.
20. +)-ATPase. J. Biol. Chem. 260: 1075-1080, 1985.
21. +)-ATPase by insulin/insulin-like growth factor-1 in cultured rat astrocytes. Biochim. Biophys. Acta 307: 175-182, 1993.
22. McDonough, A. A., and R. A. Farley. Regulation of Na,K-ATPase activity. Curr. Opin. Nephrol. Hypertens. 2: 725-734, 1993.
23. Murphy, L. J., A. Ghahary, and S. Chakrabarti. Insulin regulation of IGF-I expression in rat aorta. Diabetes 39: 657-661, 1990.
24. +-ATPase activity and its all subunit gene expression in rat skeletal muscle: influence of diabetes, fasting, and refeeding. Metabolism 41: 56-63, 1992.
25. +-ATPase in rat aorta. Diabetes 40: 1560-1563, 1991.
26. +)-adenosine triphosphatase in the rate adipocyte plasma membrane. J. Biol. Chem. 257: 11946-11952, 1982.
27. +)-ATPase transport activity in muscle. J. Biol. Chem. 260: 6206-6212, 1985.
28. +-ATPase. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H350-H353, 1994.
29. +-ATPase activity in rat aorta. Diabetologia 36: 212-217, 1993.
30. Standley, P. R. Stretch regulation of autocrine IGF-I and nitric oxide in arterial smooth muscle cells (ASMC): implications in abnormal vascular growth. Fiftieth Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research Chicago September 1996, Abstract No. 240.
31. Standley, P. R., J. L. Ram, and J. R. Sowers. The vasculature as an insulin-sensitive tissue: implications of insulin and insulin-like growth factors in hypertension, diabetes, atherosclerosis and arterial smooth muscle growth. In: Calcium-Regulating Hormones and Cardiovascular Function, edited by M. F. Crass and L. V. Avioli. Boca Raton, FL: CRC, 1995, p. 275-293.
32. Standley, P. R., J. L. Ram, and J. R. Sowers. Insulin attenuation of vascular smooth muscle calcium responses in Zucker lean and obese rats. Endocrinology 133: 1693-1699, 1993.
33. Steinberg, H. O., G. Brechtel, A. Johnson, N. Fineberg, and A. D. Baron. Insulin-mediated skeletal muscle vasodilation is nitric oxide-dependent: a novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94: 1172-1179, 1994.
34. Sung, C. K. Insulin receptor signalling through non-tyrosine kinase pathways: evidence from anti-receptor antibodies and insulin receptor mutants. J. Cell. Biochem. 8: 26-32, 1992.
35. +-ATPase gene expression by insulin in vascular smooth muscle cells. Am. J. Hypertens. 6: 626-629, 1993.
36. Walsh, M. F., M. Barazi, G. Pete, R. Muniyappa, J. C. Dunbar, and J. R. Sowers. IGF-I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 137: 1798-1803, 1996.
37. Weiner, C. P., I. Lizasoain, S.A. Baylis, R. G. Knowles, I. G. Charles, and S. Moncada. Induction of calcium-dependent nitric oxide synthase by sex hormones. Proc. Natl. Acad. Sci. USA 91: 5212-5216, 1994.
38. Weissberg, P. L., P. J. Little, E. J. Cragoe, and A. Bobik. Na-H antiport in cultured rat aortic smooth muscle: its role in cytoplasmic pH regulation. Am. J. Physiol. 253 (Cell Physiol. 22): C193-C198, 1987.
39. Williams, B., and R. W. Schrier. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41: 1464-1472, 1992.
40. Yamamoto, K., U. Tkeda, K. Okada, T. Saito, K. Kawakami, and K. Shimada. Sodium ion mediated regulation of Na/K-ATPase gene expression in vascular smooth muscle cells. Cardiovasc. Res. 28: 957-962, 1994.